什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001496201
申报总市值
US$7.7亿
US$7.7亿
113 檔
22.9%
在 Q2 2024 的 13F 官方备案中,Sphera Funds Management LTD. 管理的美股投资组合规模来到 US$7.7亿,整体持股档数为 113 档。
在 Q2 2024,Sphera Funds Management LTD. 操作展现出积极扩展与加仓意向。本季共新建仓 16 个新仓位,并对 12 个既有持股进行加仓(合计增持 28 档),相较减仓与清仓仓位显著占优。
在资产配置集中度方面,Sphera Funds Management LTD. 的前 5 大核心持股(包含 TEVA, SMH, BBIO 等)合计占整体申报市值的 22.9%,反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
SMH
市值: US$3905.3万
本季最大获利了结 / 清仓标的
XBI
前期市值: US$3605.8万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 8.99% | +1.19% | -19.20% | |
| 2 | SMH | Vaneck Semiconductor ETF | ETF-其他 | 5.33% | — | — | |
| 3 | BBIO | Bridgebio Pharma Inc | 股票-医疗保健 | 3.85% | -0.51% | +75.27% | |
| 4 | SNY | Sanofi-adr | 股票-医疗保健 | 2.97% | -0.56% | -10.01% | |
| 5 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 2.84% | +0.43% | +36.66% | |
| 6 | AMZN | Amazon.com Inc | 股票-周期性消费 | 2.67% | -1.06% | EXIT | |
| 7 | NICE | Nice LTD - Spon Adr | 股票-科技 | 2.66% | -0.10% | EXIT | |
| 8 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 2.30% | +0.20% | +1.12% | |
| 9 | META | Meta Platforms Inc-class A | 股票-通信服务 | 2.30% | — | +31.45% | |
| 10 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 2.13% | — | +77.40% | |
| 11 | PRAX | Praxis Precision Medicines I | 股票-其他 | 2.02% | +0.55% | NEW | |
| 12 | AZNN | Astrazeneca Plc-spons Adr | 股票-其他 | 2.02% | — | — | |
| 13 | MSFT | Microsoft CORP | 股票-科技 | 2.01% | — | +19.53% | |
| 14 | AAPL | Apple Inc | 股票-科技 | 1.77% | — | +251.43% | |
| 15 | KURA | Kura Oncology Inc | 股票-其他 | 1.72% | +0.04% | — | |
| 16 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.65% | -0.13% | +0.10% | |
| 17 | LLY | Eli Lilly & Co | 股票-医疗保健 | 1.63% | -0.06% | -7.05% | |
| 18 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.56% | -0.06% | +11.65% | |
| 19 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 1.52% | +0.05% | -6.02% | |
| 20 | BIIB | Biogen Inc | 股票-医疗保健 | 1.50% | +2.85% | -32.89% | |
| 21 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 1.50% | — | — | |
| 22 | SKYE | Skye Bioscience Inc | 股票-其他 | 1.42% | -0.01% | — | |
| 23 | JSPR | Jasper Therapeutics Inc | 股票-其他 | 1.41% | — | -10.10% | |
| 24 | JNJ | Johnson & Johnson | 股票-医疗保健 | 1.39% | -0.16% | -12.53% | |
| 25 | ASML | ASML Holding N.V. | 股票-科技 | 1.38% | — | — | |
| 26 | ✓ | Merus N V | 股票-其他 | 1.19% | — | -1.14% | |
| 27 | CRM | Salesforce Inc | 股票-科技 | 1.18% | — | — | |
| 28 | ✓ | Immatics NV | 股票-其他 | 1.16% | -0.14% | +9.76% | |
| 29 | CATX | Perspective Therapeutics Inc | 股票-其他 | 1.07% | — | — | |
| 30 | PHVS | Pharvaris N.V. | 股票-其他 | 1.03% | — | +2.64% | |
| 31 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 1.01% | +0.05% | -42.47% | |
| 32 | RZLT | Rezolute Inc | 股票-其他 | 1.00% | — | +71.36% | |
| 33 | CYBNEUR | Cybin Inc | 股票-其他 | 0.95% | — | — | |
| 34 | VIGL | Vigil Neuroscience Inc | 股票-其他 | 0.92% | — | -2.21% | |
| 35 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 0.91% | — | — | |
| 36 | ✓ | Inozyme Pharma Inc | 股票-其他 | 0.89% | — | +6.54% | |
| 37 | ABBV | Abbvie Inc | 股票-医疗保健 | 0.89% | -0.05% | — | |
| 38 | PANW | Palo Alto Networks Inc | 股票-科技 | 0.83% | -1.34% | EXIT | |
| 39 | S | Sentinelone Inc -class A | 股票-科技 | 0.81% | — | -48.48% | |
| 40 | TSEM | Tower Semiconductor Ltd. | 股票-科技 | 0.80% | -0.38% | -16.70% | |
| 41 | AMAT | Applied Materials Inc | 股票-科技 | 0.79% | +1.04% | NEW | |
| 42 | ENPH | Enphase Energy Inc | 股票-科技 | 0.77% | -0.86% | EXIT | |
| 43 | NVS | Novartis Ag-sponsored Adr | 股票-医疗保健 | 0.73% | +0.12% | — | |
| 44 | ACAD | Acadia Pharmaceuticals Inc | 股票-医疗保健 | 0.73% | +0.27% | +45.57% | |
| 45 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 0.71% | -0.59% | -32.79% | |
| 46 | FDMT | 4d Molecular Therapeutics In | 股票-其他 | 0.69% | — | +49.56% | |
| 47 | MU | Micron Technology Inc | 股票-科技 | 0.66% | — | — | |
| 48 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.65% | — | -29.43% | |
| 49 | CPRX | Catalyst Pharmaceuticals Inc | 股票-医疗保健 | 0.61% | — | — | |
| 50 | RCKT | Rocket Pharmaceuticals Inc | 股票-其他 | 0.61% | — | +12.63% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | SMH | Vaneck Semiconductor ETF | +5.3% | NEW | 新建仓 |
| 2 | QQQ | Invesco Qqq Trust Series 1 | +1.5% | NEW | 新建仓 |
| 3 | SKYE | Skye Bioscience Inc | +1.4% | NEW | 新建仓 |
| 4 | ASML | ASML Holding N.V. | +1.4% | NEW | 新建仓 |
| 5 | AAPL | Apple Inc | +1.4% | +251.43% | 加仓 |
| 6 | AMZN | Amazon.com Inc | +1.3% | +86.35% | 加仓 |
| 7 | CRM | Salesforce Inc | +1.2% | NEW | 新建仓 |
| 8 | SRPT | Sarepta Therapeutics Inc | +1.1% | +77.40% | 加仓 |
| 9 | BBIO | Bridgebio Pharma Inc | +1.1% | +75.27% | 加仓 |
| 10 | CATX | Perspective Therapeutics Inc | +1.1% | NEW | 新建仓 |
| 11 | IONS | Ionis Pharmaceuticals Inc | +0.9% | NEW | 新建仓 |
| 12 | PANW | Palo Alto Networks Inc | +0.8% | NEW | 新建仓 |
| 13 | MU | Micron Technology Inc | +0.7% | NEW | 新建仓 |
| 14 | RZLT | Rezolute Inc | +0.6% | +71.36% | 加仓 |
| 15 | META | Meta Platforms Inc-class A | +0.6% | +31.45% | 加仓 |
| 16 | LRCXEUR | Lam Research CORP | +0.5% | NEW | 新建仓 |
| 17 | SVRA | Savara Inc | +0.5% | NEW | 新建仓 |
| 18 | PRAX | Praxis Precision Medicines I | +0.5% | +102.34% | 加仓 |
| 19 | ELDN | Eledon Pharmaceuticals Inc | +0.5% | NEW | 新建仓 |
| 20 | NTLA | Intellia Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 21 | ADI | Analog Devices Inc | +0.4% | NEW | 新建仓 |
| 22 | PTCT | Ptc Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 23 | MSFT | Microsoft CORP | +0.4% | +19.53% | 加仓 |
| 24 | KLAC | Kla CORP | +0.4% | NEW | 新建仓 |
| 25 | HOWL | Werewolf Therapeutics Inc | -0.4% | — | 不变 |
| 26 | OTLK | Outlook Therapeutics Inc | -0.4% | -0.00% | 减仓 |
| 27 | ALNY | Alnylam Pharmaceuticals Inc | -0.4% | EXIT | 清仓 |
| 28 | SNDX | Syndax Pharmaceuticals Inc | -0.4% | +1.12% | 加仓 |
| 29 | TBLA | Taboola.com Ltd. | -0.4% | -43.97% | 减仓 |
| 30 | VTYXUSD | Ventyx Biosciences Inc | -0.5% | +2.01% | 加仓 |
| 31 | WIX | Wix.com Ltd. | -0.5% | -52.39% | 减仓 |
| 32 | NICE | Nice LTD - Spon Adr | -0.5% | +32.23% | 加仓 |
| 33 | DAWNGBX | Day One Biopharmaceuticals I | -0.5% | -29.43% | 减仓 |
| 34 | MLYS | Mineralys Therapeutics Inc | -0.5% | -32.79% | 减仓 |
| 35 | CYBNEUR | Cybin Inc | -0.5% | — | 不变 |
| 36 | ✓ | Inozyme Pharma Inc | -0.6% | +6.54% | 加仓 |
| 37 | BIIB | Biogen Inc | -0.6% | -32.89% | 减仓 |
| 38 | SEDG | Solaredge Technologies Inc | -0.7% | EXIT | 清仓 |
| 39 | JSPR | Jasper Therapeutics Inc | -0.7% | -10.10% | 减仓 |
| 40 | INCY | Incyte CORP | -0.7% | EXIT | 清仓 |
| 41 | GLBE | Global-E Online Ltd. | -0.7% | -67.97% | 减仓 |
| 42 | FROG | JFrog Ltd. | -0.8% | -47.46% | 减仓 |
| 43 | CAMT | Camtek Ltd. | -0.9% | -97.41% | 减仓 |
| 44 | NVMI | Nova Ltd. | -0.9% | EXIT | 清仓 |
| 45 | MRK | Merck & Co. Inc. | -0.9% | -42.47% | 减仓 |
| 46 | TEVA | Teva Pharmaceutical-sp Adr | -1% | -19.20% | 减仓 |
| 47 | S | Sentinelone Inc -class A | -1% | -48.48% | 减仓 |
| 48 | ✓ | Fusion Pharmaceuticals Inc | -1.4% | EXIT | 清仓 |
| 49 | ISREUR | Isoray Inc | -2.1% | EXIT | 清仓 |
| 50 | XBI | Ss Spdr S&p Biotech ETF | -5.1% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案,Sphera Funds Management LTD. 在 Q2 2024 季度的美股持仓总市值约为 US$7.7亿,共申报了 113 个公开持股仓位。
在 Q2 2024 季度,Sphera Funds Management LTD. 按市值排列的前三大核心持股分别为:TEVA (9.0%)、SMH (5.3%)、BBIO (3.9%)。其中最大持股仓位 TEVA 占据整体投资组合约 9.0% 的权重。
在 Q2 2024 季度中,Sphera Funds Management LTD. 共进行了 48 项持仓异动,包含新建仓 16 个仓位、加仓 12 个仓位、减仓 13 个仓位以及清仓 7 个仓位。 其中最大新建仓标的为 SMH。 本季清仓仓位包含 XBI。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。